TMCnet News

Antares' Healthcare Commitments Reach More Than $3.5 Billion
[September 12, 2019]

Antares' Healthcare Commitments Reach More Than $3.5 Billion


Antares announced today that it closed more than 35 healthcare industry transactions year-to-date, bringing total commitments to healthcare borrowers to more than $3.5 billion. Throughout 2019 Antares has supported the refinancing and growth initiatives of existing borrowers while also closing transactions with 18 new borrowers.

Since reentering the healthcare lending market in August 2015 under new ownership, Antares has grown its healthcare portfolio to 84 borrowers across more than 50 private equity sponsors.

"We have a longstanding commitment to the healthcare industry," said Daniel Barry, senior managing director for Antares. "That translates into a keen understanding of the challenges and opportunities transforming the industry from a business model, technological and cultural perspective. It also allows us to evaluate transactions and commit quickly, ultimately delivering the liquidity and flexibility our borrowers rely on to meet their growth objectives."

Throughout the year, Antares has utilized its industry expertise to meet the needs of clients across 15 healthcare subsectors, including but not limited to, behavioral health, contract manufacturing, healthcare IT, hospice, insurance services, medical devices, pharmaceuticals, physician practices and revenue cycle management.

Select 2019 transactions in which Antares served as administrative agent and lead left arranger include:

  • 1st lien credit facility to Aspen Medical Products (Cortec Group)
  • 1st lien creditfacility to Aspen Surgical (Audax Group)
  • Unitranche facility to Comprehensive Pharmacy Services (Frazier Healthcare Partners)
  • 1st lien credit facility to Cold Chain Technologies (Aurora Capital Partners)
  • 1st lien credit facility to Gelest (New Mountain Capital)
  • 1st lien credit facility to Orthopaedic & Neurosurgery Specialists (Kohlberg & Company)
  • Unitranche facility to Sightpath Medical (Charlesbank Capital Partners)



"As private equity investment in the sector remains high, the number of opportunities we're reviewing for potential investment has increased nearly 20 percent year to date," said Barry. "We expect this robust level of activity to continue, and we look forward to utilizing the in-depth knowledge of our industry experts to support the needs of our private equity healthcare sponsors and borrowers."

About Antares


With approximately $24 billion of capital under management and administration as of December 31, 2018, Antares is a private debt credit manager and leading provider of financing solutions for middle-market private equity-backed transactions. In 2018, Antares issued nearly $25 billion in financing commitments to borrowers through its robust suite of products including first lien revolvers, term loans and delayed draw term loans, 2nd lien term loans, unitranche facilities and equity investments. Antares world-class capital markets experts hold relationships with over 400 banks and institutional investors allowing the firm to structure, distribute and trade syndicated loans on behalf of its customers. Since its founding in 1996, Antares has been recognized by industry organizations as a leading provider of middle market private debt, most recently being named the 2018 Lender of the Year by ACG New York. The company maintains offices in Atlanta, Chicago, Los Angeles, New York and Toronto. Visit Antares at www.antares.com or follow the company on Twitter (News - Alert) at www.twitter.com/antarescapital. Antares Capital is a subsidiary of Antares Holdings LP., collectively ("Antares").


[ Back To TMCnet.com's Homepage ]